UC San Diego has joined a Phase II clinical trial to evaluate various additional COVID-19 booster shots. The trial seeks to understand if different vaccine regimens can broaden immune responses in adults who already have received a primary vaccination series and a first booster shot.
Related Articles

News
UC San Diego Opens the Design and Innovation Building
November 18, 2021
sandiegobiotech
News, UCSD News
Comments Off on UC San Diego Opens the Design and Innovation Building
As a billion-dollar research enterprise in the heart of one of the most densely concentrated innovation hubs in the nation, UC San Diego is a unique place where fresh ideas are translated into solutions to benef… […]

News
Elizabeth Villa Selected as 2021 HHMI Investigator
September 23, 2021
sandiegobiotech
News, UCSD News
Comments Off on Elizabeth Villa Selected as 2021 HHMI Investigator
Biological Sciences Associate Professor Elizabeth Villa has been selected as a 2021 Howard Hughes Medical Institute (HHMI) Investigator. As one of 33 scientists chosen out of pool of more than 800, Villa will re… […]

News
Artificial Intelligence Could Be New Blueprint for Precision Drug Discovery
July 12, 2021
sandiegobiotech
News
Comments Off on Artificial Intelligence Could Be New Blueprint for Precision Drug Discovery
Researchers at University of California San Diego School of Medicine describe a new approach that uses machine learning to hunt for disease targets and then predicts whether a drug is likely to receive FDA approval. Click here to view original post… […]